Image

    Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata

    September 2022 in “ Dermatology and therapy ”
    Kun-Wei Lai, Tsen‐Fang Tsai
    Studysummary This review summarizes current evidence on the use of contact immunotherapy, excluding alopecia areata, for various skin diseases, discussing its safety, efficacy, and the underlying mechanisms as reported from studies in the PubMed database.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on link.springer.com →
    Discuss this study in the Community →

    Research cited in this study 20

    1. Italian Guidelines in Diagnosis and Treatment of Alopecia Areata Giornale italiano di dermatologia e venereologia · 2019
    2. Alopecia Areata: Treatment Options and Efficacy Journal of the American Academy of Dermatology · 2017
    3. Angioedema After Squaric Acid Treatment in a 6-Year-Old Girl Pediatric Dermatology · 2016
    4. Childhood Epidermolysis Bullosa Acquisita During Squaric Acid Dibutyl Ester Immunotherapy for Alopecia Areata British Journal of Dermatology · 2016
    5. Hapten-Induced Lymphadenosis Benigna Cutis Secondary to Squaric Acid Dibutylester Sensitization for Alopecia Areata The Journal of Dermatology · 2014
    6. Extensive Scalp Angioedema Following High-Dose Diphenylcyclopropenone for Alopecia Areata Hospital pharmacy · 2014
    7. Diphenylcyclopropenone-Induced Vitiligo in a Patient with Alopecia Universalis Case reports in dermatology · 2013
    8. British Association of Dermatologists’ Guidelines for the Management of Alopecia Areata 2012 British Journal of Dermatology · 2012
    9. Diphencyprone Induced Vitiligo: A Case Report Case reports in medicine · 2012
    10. Pigmented Contact Dermatitis Due to Therapeutic Sensitizer as a Complication of Contact Immunotherapy in Alopecia Areata Journal of dermatology · 2010
    11. Vitiligo After Diphencyprone for Alopecia Areata Dermatology Research and Practice · 2010
    12. Discoid Lupus Erythematosus Exacerbated by Contact Dermatitis Caused by Use of Squaric Acid Dibutylester for Topical Immunotherapy in a Patient with Alopecia Areata The Journal of Dermatology · 2008
    13. Allergic Contact Dermatitis from Dyes in Wigs Following Diphenylcyclopropenone Treatment Contact dermatitis · 2004
    14. The Therapeutic Use of Topical Contact Sensitizers in Benign Dermatoses British journal of dermatology/British journal of dermatology, Supplement · 2001
    15. Severe Dermographism After Topical Therapy With Diphenylcyclopropenone for Alopecia Universalis Contact dermatitis · 2000
    16. Topical Immunotherapy in Dermatology International Journal of Clinical Practice · 1999
    17. Diphenylcyclopropenone: An Important Agent Known to Cause Depigmentation Dermatology · 1999
    18. Vitiligo Complicating Diphencyprone Sensitization Therapy for Alopecia Universalis British Journal of Dermatology · 1995
    19. Vitiligo as a Reaction to Topical Treatment with Diphencyprone Dermatology · 1988
    20. Adverse Systemic Reaction to Dinitrochlorobenzene Archives of Dermatology · 1982

    Related research 1

    1. Twenty Nail Dystrophy with Alopecia Areata in an Atopic Child International journal of research in dermatology · 2019